A trial of music therapy compared to music listening for children with autism spectrum disorders

ISRCTN ISRCTN31179114
DOI https://doi.org/10.1186/ISRCTN31179114
Secondary identifying numbers 010914
Submission date
03/01/2020
Registration date
10/02/2020
Last edited
16/09/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
This study addresses a fundamental, so far unanswered question: is Music Therapy more effective than just music listening? This question is very important, because its answer has so far only been assumed, and could encourage or discourage the use of music therapy. The question is addressed through a trial of music therapy compared to music listening for children with autism spectrum disorders. The number of participants and intervention length (25 sessions over 8 months) raises the standards of existing, similar studies.

Who can participate?
Children aged 4 to 7 years with a diagnosis of ASD

What does the study involve?
The study involves either 25 sessions of music therapy with a qualified music therapist or 25 sessions of music listening with no therapy. These 25 sessions take place over a period of 8 months and at the start and end of the study, participants will be evaluated on the basis of overall functioning and autistic symptom severity.

What are the possible benefits and risks of participating?
There are no known risks of musicotherapy for children suffering from autism disorder. The potential benefits are improvements in social skills and speech expression and reduced anxieties and repetitive behaviors.

Where is the study run from?
Nantes Child Psychiatric Hospital (France)

When is the study starting and how long is it expected to run for?
May 2014 to June 2015

Who is funding the study?
Entreprendre pour Aider (France) and the Académie Française (France)

Who is the main contact?
Professor Thomas Rabeyron
Thomas.rabeyron@univ-lorraine.fr

Contact information

Prof Thomas Rabeyron
Scientific

23 Boulevard Albert Premier
Nancy
54000
France

ORCiD logoORCID ID 0000-0003-4117-4683
Phone +33 372743058
Email Thomas.rabeyron@univ-lorraine.fr

Study information

Study designAn interventional, longitudinal, single-centre, single-blinded, randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleA randomized controlled trial of 25 sessions of music therapy in autism spectrum disorders: MUSICAUTISM
Study acronymMUSICAUTISM
Study objectivesMusic Therapy will be more effective than Music Listening in general clinical evaluations.

Music Therapy will be more effective than Music Listening in general clinical evaluations for symptoms related to interactions in ASD-specific dimensions
Ethics approval(s)Approved 12/05/2014, the ethics committee of the Nantes University Hospital Centre (5 allée de l’ile gloriette 44000 Nantes Immeuble Jean Monnet, RH, 30 boulevard Jean Monnet 44093 Nantes Cedex 1; bp-uupea@chu-nantes.fr; +33 0253482653), ref: 015321653
Health condition(s) or problem(s) studiedAutism spectrum disorders
InterventionChildren were randomly assigned to one of the two groups: music therapy (MT) or music listening (ML), using a generated randomization list for each group.

At enrolment baseline evaluations to assess global functioning took place.

Half of the participants were assigned to the MT group where they received 25 sessions of MT with a qualified music therapist. The other half were assigned to the ML group which involved 25 sessions of ML with no therapeutic intervention. The 25 sessions for each group took place over a period of 8 months.

A second evaluation was performed for both groups after 8 months.
Intervention typeBehavioural
Primary outcome measureImprovement in patient global functioning measured by the Clinical Global Impressions Scale (CGI) at baseline and 8 months
Secondary outcome measuresAutistic symptom severity measured by the Childhood Autism Rating Scale (CARS) and the Autism Behaviour Checklist (ABC) at baseline and 8 months
Overall study start date01/05/2014
Completion date06/06/2015

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit4 Years
Upper age limit7 Years
SexBoth
Target number of participants37
Total final enrolment36
Key inclusion criteria1. Childhood Autism Rating Scale (CARS)-validated diagnosis of ASD
2. Aged 4 to 7 years
Key exclusion criteria1. Auditory impairment
2. Known somatic and neurological diseases (with the exception of stabilized epilepsy)
3. Psychotropic medication that was modified less than 6 months prior to the study
4. Behavioral disturbance incompatible with an MT or ML session
Date of first enrolment01/07/2014
Date of final enrolment01/09/2014

Locations

Countries of recruitment

  • France

Study participating centre

Nantes Child Psychiatric Hospital
Immeuble Jean Monnet
RH
30 boulevard Jean Monnet
Nantes
44093 Nantes Cedex 1
France

Sponsor information

Unité universitaire de psychiatrie de l'enfant et de l'adolescent
Hospital/treatment centre

Immeuble Jean Monnet
RH
30 boulevard Jean Monnet
Nantes
44093 Nantes Cedex 1
France

Phone +33 0253482653
Email olivier.bonnot@gmail.com
Website https://www.chu-nantes.fr/unite-universitaire-de-psychiatrie-de-l-enfant-et-de-l-adolescent-37370.kjsp

Funders

Funder type

Charity

Entreprendre pour Aider

No information available

Academie Francaise

No information available

Results and Publications

Intention to publish date15/01/2020
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe Journal of Child Psychology and Psychiatry
IPD sharing planThe datasets generated during and/or analyzed during the current study are/will be available upon request from Juan-Pablo Robledo del Canto. Datasets consist of Excel files containing the different measurements at t0 and t1. Raw data for all measurements and analysis will be sent by mail. Because consent was obtained from participants, anonymized data will be shared at the researcher’s discretion.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2020 16/09/2020 Yes No

Editorial Notes

16/09/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
03/02/2020: Trial’s existence confirmed by the University Unit of Child and Adolescent Psychiatry of the Nantes University Hospital Centre.